Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Plant is part of the company's CAD $30 million capital investment in the site
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
Subscribe To Our Newsletter & Stay Updated